Renaissance Technologies (RenTech)'s NPCE Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 174,311 shares of NeuroPace, Inc. (NPCE) worth $2.29 M, representing 0.00% of the portfolio. First purchased in 2022-Q2, this medium-term investment has been held for 16 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in NPCE, demonstrating sustained confidence in this investment. Largest addition occurred in Q4 2025, adding 93,200 shares. Largest reduction occurred in Q1 2026, reducing 47,989 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s NeuroPace (NPCE) Holding Value Over Time
Track share changes against reported price movement
Quarterly NeuroPace (NPCE) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | -47,989 | Reduce 21.59% | 174,311 | $13.15 |
| Q4 2025 | +93,200 | Add 72.19% | 222,300 | $15.44 |
| Q3 2025 | -17 | Reduce 0.01% | 129,100 | $10.31 |
| Q2 2025 | -26,683 | Reduce 17.13% | 129,117 | $11.14 |
| Q1 2025 | +69,500 | Add 80.53% | 155,800 | $12.29 |
| Q4 2024 | -700 | Reduce 0.80% | 86,300 | $11.19 |
| Q3 2024 | +5,800 | Add 7.14% | 87,000 | $6.97 |
| Q2 2024 | -38,771 | Reduce 32.32% | 81,200 | $7.56 |
| Q1 2024 | +11,646 | Add 10.75% | 119,971 | $13.20 |
| Q4 2023 | +64,040 | Add 144.61% | 108,325 | $10.31 |
| Q3 2023 | +26,985 | Add 155.98% | 44,285 | $9.73 |
| Q2 2023 | +2,800 | Add 19.31% | 17,300 | $0.00 |
| Q1 2023 | +1,100 | Add 8.21% | 14,500 | $0.00 |
| Q4 2022 | +200 | Add 1.52% | 13,400 | $0.00 |
| Q3 2022 | +500 | Add 3.94% | 13,200 | $3.79 |
| Q2 2022 | +12,700 | New Buy | 12,700 | $4.96 |
Renaissance Technologies (RenTech)'s NeuroPace Investment FAQs
Renaissance Technologies (RenTech) first purchased NeuroPace, Inc. (NPCE) in Q2 2022, acquiring 12,700 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held NeuroPace, Inc. (NPCE) for 16 quarters since Q2 2022.
Renaissance Technologies (RenTech)'s largest addition to NeuroPace, Inc. (NPCE) was in Q4 2025, adding 222,300 shares worth $3.43 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 174,311 shares of NeuroPace, Inc. (NPCE), valued at approximately $2.29 M.
As of the Q1 2026 filing, NeuroPace, Inc. (NPCE) represents approximately 0.00% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in NeuroPace, Inc. (NPCE) was 222,300 shares, as reported at the end of Q4 2025.